Tha novo catalytic synthesis of aminoacids from CO2
This proposal deals with the development of an innovative and unconventional catalytic de novo approach to β-amino acids, compounds of remarkable biological significance, using simple, available and abundant carbon dioxide (CO2) a...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
ORGANO-CAS CAT
ORGANO CASCADE CATALYSIS A SHORTCUT TO STEREOCHEMICAL AND M...
174K€
Cerrado
CASAA
Catalytic asymmetric synthesis of amines and amides
2M€
Cerrado
CTQ2010-19999
REACCIONES DE ADICION Y SUSTITUCION CATLIZADAS POR ORO: SELE...
136K€
Cerrado
CTQ2017-88451-R
GENERACION NO CONVENCIONAL DE REACTIVOS ORGANOMETALICOS CATA...
71K€
Cerrado
PHOTOZYME
Enhancing the Potential of Enzymatic Catalysis with Light
3M€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
This proposal deals with the development of an innovative and unconventional catalytic de novo approach to β-amino acids, compounds of remarkable biological significance, using simple, available and abundant carbon dioxide (CO2) as C1 synthon. Specifically, NOVOCAT will promote a synergistic catalytic C-N bond-cleavage/CO2 insertion event of readily available aziridines from a synergistic and rather challenging C-N cleavage/CO2 insertion event. The project will offer all the necessary understanding behind the factors influencing both C-N bond-cleavage and the subsequent CO2 insertion event, thus opening up new horizons in preparative organic chemistry as well as offering solutions to a social, industrial and academic problem such as the use of CO2 as chemical feedstock. NOVOCAT´s design will allow for promoting a counterintuitive catalytic desymmetrization or dynamic kinetic resolution events of aziridines with CO2 en route to β-amino acids. This proposal will lead to new knowledge in synthetic design, thus providing new logics in retrosynthetic analysis that will likely attract the interest of both pharmaceutical and industrial laboratories.